Inflammation
‘Best expectation’: Vaccine responses may prevent, delay cancer relapse
A personalized cancer vaccine produced T-cell responses in certain patients with head and neck squamous cell carcinoma, according to results from a randomized study presented at American Association for Cancer Research Annual Meeting.
VIDEO: Alphyn's AB-101a shows ‘market-leading’ results in atopic dermatitis
SAN DIEGO — In this Healio video perspective from the American Academy of Dermatology Annual Meeting, Alphyn Biologics CEO Neal Koller discusses new data from the company’s phase 2a trial of AB-101a for the treatment of atopic dermatitis.
VIDEO: Check for signs of uveitis-glaucoma-hyphema syndrome when repositioning IOLs
TAMPA, Fla. — In a presentation from Telling It Like It Is, María H. Berrocal, MD, FASRS, uses surgical footage to showcase techniques for repositioning an IOL, including in patients with uveitis-glaucoma-hyphema syndrome.
Extreme heat exposure may impair immune response, increase inflammation
Researchers in Kentucky identified mechanisms by which heat exposure caused immune response that may increase inflammation.
Psoriasis biomarkers modulated with TAK-279 treatment
SAN DIEGO — Modulation of psoriasis biomarkers and pathways were observed in patients who experienced clinical success with TAK-279, according to phase 2b trial results.
Richard L. Lindstrom, MD, appointed founder, chairman of Surface Ophthalmics
Healio | OSN Chief Medical Editor Richard L. Lindstrom, MD, a leader in corneal, cataract, refractive and laser surgery, has been appointed as founder and chairman of Surface Ophthalmics, according to a press release.
New legislation may tame ‘wild west’ of cannabis research in rheumatology
A law allowing for medical cannabis research could have far-reaching implications in rheumatology and across the health care spectrum, but there are still significant hurdles to clear before cannabinoids become part of routine care.
FDA grants priority review to dupilumab for COPD with type 2 inflammation
The FDA has granted priority review to dupilumab to treat adults with uncontrolled COPD with type 2 inflammation, according to a manufacturer-issued press release.
Plant-based topical successfully targets both inflammation, bacteria in atopic dermatitis
MIAMI BEACH, Fla. — Zabalafin, a nonsteroidal topical, demonstrated efficacy in reducing inflammation and bacteria on the skin of children and adults with atopic dermatitis, according to interim data presented in a poster at Masters of Pediatric Dermatology.
VIDEO: Dextenza demonstrates positive real-world safety
TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Steven M. Silverstein, MD, FACS, discusses safety data for Dextenza for the treatment of perioperative ocular pain and inflammation and allergic conjunctivitis.